Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added to the page. Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:20:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page history. This appears to be a minor site version update with no substantive changes to study data or navigation.
    Difference
    0.0%
    Check dated 2026-02-11T11:52:00.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-04T10:27:17.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary visibility controls and color-coded highlights for additions and deletions were added to the study history page. Revision notes now show 'Revision: v3.4.0', and 'No FEAR Act Data' was removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.4, replacing v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:51:30.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the footer, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-23T21:12:06.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.